HIV and Infection Risk: Understanding Immune System Vulnerability
Why HIV Increases Infection Susceptibility
HIV targets CD4⁺ T helper cells, the orchestrators of adaptive immunity. Their depletion creates a multi-layered immune deficit:
- CD4⁺ T-cell loss: Direct infection and bystander apoptosis reduce numbers below the functional threshold (<200 cells/µL = AIDS).
- Impaired residual CD4⁺ function: Even surviving cells show defective proliferation, cytokine production, and memory formation.
- Chronic immune activation: Persistent viral replication drives inflammation, exhausting immune cells and damaging lymphoid architecture.
- Opportunistic infections (OIs): Pathogens controlled by intact immunity reactivate or cause severe disease:
- Bacterial: TB, Pneumocystis, bacterial pneumonia
- Fungal: Cryptococcus, Histoplasma, Coccidioides
- Viral: CMV, HSV, VZV, KSHV (Kaposi sarcoma)
- Parasitic: Toxoplasma, Cryptosporidium
- Latent infection reactivation: Especially TB (lifetime risk 10%/year with HIV vs. 10% lifetime without).
- Mucosal barrier breakdown: Gut CD4⁺ depletion → microbial translocation → systemic inflammation.
- Humoral immunity impairment: B-cell dysregulation → poor antibody responses to new antigens and vaccines.
ART Transforms Outcomes
Effective antiretroviral therapy (ART) suppresses viremia, restores CD4⁺ counts, reverses immune activation, and prevents most opportunistic infections. With early treatment, life expectancy approaches normal.
HIV & AIDS - Related Articles
- Understanding Discrimination Faced by People with HIV/AIDS
- HIV Cannot Spread Through Mosquito Bites or Ingestion
- HIV Cannot Survive in Soft Drinks: Virus Is Too Fragile Outside the Body
- Understanding HIV Diagnosis: Symptoms, Transmission & Support
- HIV and Needle Sharing: Risks, Transmission Routes & Prevention
- Understanding the Emotional Impact of HIV and AIDS
- Understanding AIDS Treatment Effectiveness & Life Expectancy
